How Does Hysterectomy Affect Hormones?

Hysterectomy changes your hormonal landscape whether or not your ovaries are removed, though the extent depends heavily on the type of surgery. When both ovaries are taken out alongside the uterus, the hormonal shift is immediate and dramatic: estrogen, testosterone, and other sex hormones plummet within hours. But even when both ovaries are left in place, the surgery still nudges your hormonal balance in ways that most people don’t expect, because the uterus and ovaries share a blood supply that gets disrupted during the procedure. The distinction between these two scenarios matters enormously for long-term health.

Why Keeping Your Ovaries Doesn’t Mean Nothing Changes

A common reassurance before hysterectomy is that hormone levels will stay normal as long as the ovaries remain. Research tells a more complicated story. In a study of women aged 29 to 44 who had undergone hysterectomy with ovarian preservation, urine analysis showed that their ovulatory cycles continued at a pace similar to women with an intact uterus, with a median cycle interval of about 27 days and over 96% of measured cycles meeting the criteria for ovulation.¹ That sounds encouraging, and for many women, ovarian function does continue for years without noticeable disruption.

However, the ovaries appear to age faster after hysterectomy. A large cohort study found that women who kept both ovaries still had a significantly increased risk of ovarian failure compared to women who never had a hysterectomy, with nearly a 74% higher risk.² For women who lost one ovary during the procedure, the risk roughly tripled. So while the ovaries keep working in the short term, their functional lifespan appears to shorten, meaning menopause may arrive earlier than it otherwise would.

The Blood Supply Problem

The uterus doesn’t just sit passively next to the ovaries. The two organs share blood vessels, and during a hysterectomy the uterine arteries are tied off. Since branches of those arteries feed the ovaries, the surgery reduces ovarian blood flow even when the ovaries themselves aren’t touched. A narrative review identified three pathways through which hysterectomy impairs ovarian function: reduced blood supply from uterine artery ligation, disruption of the hormonal feedback loop involving the pituitary gland, and oxidative stress triggered by chronic inflammation at the surgical site.³

These aren’t just theoretical pathways. One study measured blood flow and hormone levels in women before and after hysterectomy, and found that within the first few months, estrogen and progesterone levels dropped significantly while FSH and LH (the brain hormones that tell your ovaries to work harder) rose.⁴ Rising FSH is one of the earliest signs that the ovaries are struggling to keep up, long before you’d notice any symptoms. A separate study confirmed that even among women who retained both ovaries, hysterectomy was associated with a 50% greater likelihood of elevated FSH levels.⁵

How Ovarian Reserve Drops After Surgery

Anti-Müllerian hormone, or AMH, is one of the best markers for how many eggs your ovaries have left. A systematic review and meta-analysis pooling data from multiple studies found that AMH levels were significantly lower in women who had undergone hysterectomy compared to those who hadn’t.⁶ The decline can begin remarkably quickly. In one study, AMH dropped by roughly 14% within just three days of surgery.⁷ While AMH naturally falls with age, the surgery appears to accelerate that trajectory. For younger premenopausal women, this means the window of remaining ovarian function may close sooner than expected.

What Happens When the Ovaries Are Removed

When both ovaries are removed along with the uterus (a procedure called bilateral oophorectomy), the hormonal consequences are far more severe and immediate. You enter what’s called surgical menopause, and the transition is dramatically faster than natural menopause. Instead of a gradual decline in estrogen over several years, your levels crash within hours of surgery.⁸ This acute drop tends to produce more intense symptoms than natural menopause, including severe hot flashes, night sweats, sleep disruption, and vaginal dryness.

A meta-analysis looking specifically at postmenopausal women who had bilateral oophorectomy found that estradiol, testosterone, and DHEA all dropped significantly compared to women who still had their ovaries.⁹ The testosterone finding deserves particular attention. People often think of testosterone as a male hormone, but the ovaries produce it throughout a woman’s life. Even after natural menopause, the ovaries remain a meaningful source. The Rancho Bernardo Study found that both total and bioavailable testosterone were reduced by more than 40% in older women who had undergone bilateral oophorectomy compared to those with intact ovaries, and women who had a hysterectomy with ovarian conservation still had roughly 10% lower androstenedione levels.¹⁰ Those testosterone losses can affect energy, muscle mass, mood, and sexual desire.

Cardiovascular and Metabolic Consequences

Estrogen plays a protective role in cardiovascular health, which is one reason heart disease rates in women rise sharply after menopause. Hysterectomy, even with ovarian preservation, appears to amplify that risk. A cohort study found that women who had a hysterectomy before age 35 faced a 4.6 times higher risk of congestive heart failure and a 2.5 times higher risk of coronary artery disease.¹¹ A large Korean study reinforced this picture: women who had early hysterectomies showed about a 25% increase in cardiovascular disease risk overall, and a 31% increase in stroke risk specifically. These associations held even after excluding women who had their ovaries removed.¹²

A Norwegian cohort study of over 15,000 women followed for many years found that hysterectomy was associated with a 30% increase in all-cause mortality and a 47% increase in cardiovascular mortality. Among women aged 52 or younger, cardiovascular mortality risk was nearly tripled.¹³ The pattern across these studies is consistent: younger age at hysterectomy correlates with greater cardiovascular risk, likely because these women lose their hormonal protection earlier in life.

The metabolic picture extends beyond the heart. The decline in ovarian hormones after hysterectomy affects how your body handles glucose. One study found a strong positive correlation between the drop in estradiol after hysterectomy and the increase in insulin resistance, and premenopausal women were hit hardest because they experienced the largest relative estrogen decline.¹⁴ Estrogen helps regulate glucose transport and supports pancreatic function, so losing it prematurely can shift your metabolic profile in ways that raise the risk of type 2 diabetes.¹⁵

Bone Health After Hysterectomy

Estrogen is essential for maintaining bone density, and losing it prematurely creates a longer window for bone loss. A large population-based cohort study found that women with a hysterectomy had roughly double the risk of osteoporosis or bone fracture compared to women who had not had the procedure.¹⁶ Even with ovarian conservation, bone density at the spine and hip was significantly reduced in one study comparing women after hysterectomy with matched controls.¹⁷ Premenopausal hysterectomy is particularly concerning because the resulting decline in ovarian reserve and long-term estrogen production means bone mineral loss accumulates over a longer stretch of years.¹⁸

If you’ve had a hysterectomy, especially before menopause, bone density screening becomes more important than it might otherwise be. The typical recommendation for a first bone density scan is age 65, but your doctor may want to test earlier if your surgery was done in your 30s or 40s.

Mood, Depression, and Cognitive Concerns

The hormonal disruption from hysterectomy doesn’t stop at physical effects. A large population-based cohort study found that women who had a hysterectomy had about a 35% higher risk of developing depression compared to women who hadn’t, with the risk being especially elevated among women in their 30s at the time of surgery.¹⁹ Whether this is driven primarily by hormonal changes, by the psychological impact of the surgery, or by both acting together is still debated. But estrogen influences serotonin and other neurotransmitter systems, so there’s a plausible biological path between the hormonal shift and mood changes.

The dementia question is more nuanced. Combined results from the Mayo Clinic and a Danish cohort study suggested a stepwise increase in dementia risk with more extensive gynecologic surgery: hysterectomy alone carried some increase, hysterectomy with removal of one ovary carried more, and bilateral oophorectomy carried the most.²⁰ The Danish cohort specifically found that early-onset dementia risk (before age 50) was significantly higher in women who had undergone hysterectomy, and the risk increased with younger age at surgery and with ovarian removal.²¹

However, a more recent pooled analysis of over 230,000 women added an important caveat: once you account for the age at which menopause occurs, the type of menopause (surgical versus natural) didn’t independently predict dementia risk. The biggest risk factor was simply reaching menopause before age 40, regardless of how that happened.²² In other words, it may be early estrogen loss itself that matters for brain health, not the surgical route per se. This distinction is meaningful for women weighing their options: if hormone therapy keeps estrogen levels adequate after surgery, the elevated risk may be avoidable.

Sexual Function and Libido

Research suggests that roughly 30% to 50% of women experience some form of sexual dysfunction after hysterectomy, including vaginal dryness, reduced desire, pain during sex, and difficulty reaching orgasm.²³ Several factors contribute. Vaginal dryness is driven directly by estrogen loss, whether from ovarian removal or from the gradual ovarian decline described earlier. Lower testosterone levels, as seen in the Rancho Bernardo data, can dampen desire independently of estrogen.¹⁰ And the surgery itself can alter pelvic nerve pathways and cervical sensation, particularly in total hysterectomies where the cervix is removed.

Not every woman experiences these problems, and some report improved sexual satisfaction after surgery, especially if the hysterectomy resolved painful conditions like endometriosis or fibroids. The hormonal contribution to sexual function can often be addressed with local estrogen therapy or, in some cases, testosterone supplementation, though the latter remains a somewhat contentious area of prescribing.

Hormone Therapy After Hysterectomy

One upside to having had a hysterectomy, if you can call it that, is that hormone replacement becomes simpler. Without a uterus, you don’t need progesterone to protect the endometrial lining, which means estrogen alone is sufficient for managing menopausal symptoms like hot flashes and vaginal atrophy.²⁴ The exception is women who had endometriosis before surgery, since residual endometrial tissue outside the uterus could still respond to unopposed estrogen.

The distinction between estrogen-only and combined (estrogen plus progestogen) therapy matters more than most people realize. The Women’s Health Initiative trial, which followed women for over 20 years, found that combined therapy increased breast cancer risk, while estrogen-only therapy given to women who had previously had a hysterectomy was actually associated with a reduced risk of developing and dying from breast cancer.²⁵ This finding flipped the narrative that dominated after the WHI’s initial results scared many women off hormone therapy entirely. For women without a uterus, estrogen-only therapy appears to carry a more favorable risk profile than the combined regimens that women with a uterus must use.

For women who cannot or choose not to take hormone therapy, non-hormonal options have expanded. The FDA approved fezolinetant (brand name Veozah), which works by blocking a receptor in the brain’s thermoregulatory center rather than replacing estrogen, offering relief from hot flashes and night sweats through an entirely different mechanism.²⁶ This class of drug is particularly relevant for women who have had hormone-sensitive cancers, or those who simply prefer to avoid hormones.

Age at Surgery Changes Everything

A thread running through nearly every outcome study is that age at the time of hysterectomy is the single most important modifier of hormonal consequences. A 30-year-old who loses ovarian function, whether immediately through oophorectomy or gradually through compromised blood supply, is losing decades of hormonal protection. The cardiovascular data bear this out, with the strongest risks concentrated in women who had surgery before 35.¹¹ The dementia data point in the same direction, with the youngest surgical patients facing the highest risks.²¹ The depression data follow the same pattern.¹⁹

For a woman who has the procedure at 55, after natural menopause has already occurred, the hormonal consequences are far smaller because her ovaries were already winding down. But for premenopausal women, the decision about whether to preserve ovaries and how aggressively to monitor hormone levels afterward deserves careful planning. The evidence strongly supports ovarian conservation whenever oncologically safe, and equally supports hormone therapy from the time of surgery until at least the average age of natural menopause (around 51) for women who undergo premature surgical menopause. The goal is to close the gap between when you lost your hormonal protection and when you would have lost it naturally, not to extend hormone exposure beyond what your body would have provided on its own.

1
PubMed. Retention of normal ovarian function after hysterectomy
2
PubMed Central. Effect of Hysterectomy With Ovarian Preservation on Ovarian Function
3
Clinical and Experimental Obstetrics & Gynecology. Post-Hysterectomy Ovarian Consequences: Mechanisms, Risks, and Clinical Management Strategies—A Narrative Review
4
PubMed. The effect of hysterectomy on ovarian blood supply and endocrine function
5
PubMed. FSH levels in relation to hysterectomy and to unilateral oophorectomy
6
PubMed Central. Effect of hysterectomy on ovarian function: a systematic review and meta-analysis
7
PubMed Central. Effect of Hysterectomy on Ovarian Reserve in the Early Postoperative Period Based on the Type of Surgery
8
PubMed. Sleep disturbance in women who undergo surgical menopause compared with women who experience natural menopause
9
PubMed Central. Changes of hormone levels for postmenopausal women after bilateral oophorectomy: A meta-analysis
10
The Journal of Clinical Endocrinology & Metabolism. Hysterectomy, Oophorectomy, and Endogenous Sex Hormone Levels in Older Women: The Rancho Bernardo Study
11
PubMed Central. Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study
12
JAMA Network Open. Association of Early Hysterectomy With Risk of Cardiovascular Disease in Korean Women
13
PubMed Central. All-cause and cardiovascular mortality after hysterectomy and oophorectomy in a large cohort (HUNT2)
14
Clinical Nutrition. Female sex hormones in relation to insulin resistance after hysterectomy: A pilot study
15
PubMed Central. Diabetes mellitus risk after hysterectomy: A population-based retrospective cohort study
16
PubMed Central. Hysterectomies are associated with an increased risk of osteoporosis and bone fracture: A population-based cohort study
17
PubMed. Bone loss after hysterectomy with ovarian conservation
18
American Journal of Obstetrics & Gynecology. Increased the risk of osteoporosis with hysterectomy: a longitudinal follow-up study using a national sample cohort
19
PubMed Central. Hysterectomies Are Associated with an Increased Risk of Depression: A Population-Based Cohort Study
20
PubMed Central. Hysterectomy, Oophorectomy, Estrogen, and the Risk of Dementia
21
PubMed. Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study
22
Age and Ageing. Menopause age and type and dementia risk: a pooled analysis of 233 802 women
23
Journal of Education, Health and Sport. Sexual disorders in a 45 –year-old patient after hysterectomy in the home
24
PubMed. Options for hormone therapy in women who have had a hysterectomy
25
PubMed Central. Could Perimenopausal Estrogen Prevent Breast Cancer? Exploring the Differential Effects of Estrogen-Only Versus Combined Hormone Replacement Therapy
26
PubMed Central. Veozah (Fezolinetant): A Promising Non-Hormonal Treatment for Vasomotor Symptoms in Menopause